Brain |
Pattern 1 |
|
Pancreatic adenocarcinoma signaling |
|
Role of CHK proteins in cell cycle checkpoint control |
|
T helper cell differentiation |
|
Cyclins and cell cycle regulation |
|
Th1 pathway |
|
Bladder cancer signaling |
|
Inhibition of angiogenesis by TSP1 |
|
Dopamine receptor signaling |
|
ILK signaling |
|
B cell development |
|
Cell cycle regulation by BTG family proteins |
|
Inhibition of matrix metalloproteases |
|
Thyroid cancer signaling |
|
HIF1α signaling |
|
Crosstalk between dendritic cells and natural killer cells |
|
Th1 and Th2 activation pathway |
|
Role of JAK family kinases in IL-6-type cytokine signaling |
|
Role of JAK1 and JAK3 in γc cytokine signaling |
|
Role of Oct4 in mammalian embryonic stem cell pluripotency |
|
Autoimmune thyroid disease signaling |
|
Spleen |
Pattern 1 |
Pattern − 1 |
Heme biosynthesis II |
cAMP-mediated signaling |
Mitotic roles of polo-like kinase |
G-Protein coupled receptor signaling |
Heme biosynthesis from uroporphyrinogen-III I |
Serine biosynthesis |
Tetrapyrrole biosynthesis II |
Superpathway of serine and glycine biosynthesis I |
Estrogen-mediated S-phase entry |
LPS/IL-1-mediated inhibition of RXR function |
GADD45 signaling |
Protein kinase A signaling |
Cell cycle: G2/M DNA damage checkpoint regulation |
Cardiac hypertrophy signaling |
Cyclins and cell cycle regulation |
Fatty acid activation |
dTMP de novo biosynthesis |
nNOS signaling in skeletal muscle cells |
Cell cycle control of chromosomal replication |
Corticotropin releasing hormone signaling |
DNA damage-induced 14-3-3σ signaling |
|
Rapoport-Luebering glycolytic shunt |
|
Pyrimidine deoxyribonucleotides de novo biosynthesis I |
|
ATM signaling |
|
Antiproliferative role of TOB in T cell signaling |
|
Role of CHK proteins in cell cycle checkpoint control |
|
Cell cycle: G1/S checkpoint regulation |
|
Cell cycle regulation by BTG family proteins |
|
Asparagine biosynthesis I |
|
γ-Glutamyl cycle |
|